We are live on ! Find out more
AMAM

Ambrx Biopharma Inc
AMAM

Delisted

AMAM was delisted on the 6th of March, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of AMAM yet.

AMAM Hedge Fund Activity: Q1 2024 in Review

0 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Ambrx Biopharma Inc (AMAM) for Q1 2024, worth a combined $0 — down 100% from $913M a quarter earlier.

Sellers outnumbered buyers: 68 funds closed out of AMAM and 0 opened new positions — a net loss of 68 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Darwin Global Management, exiting entirely with an estimated $238M sold.

  • 0 institutional investors held Ambrx Biopharma Inc (AMAM) as of Q1 2024, down from 68 in Q4 2023.
  • Funds reported $0 of Ambrx Biopharma Inc stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Ambrx Biopharma Inc positions in Q1 2024 and 68 closed out, a net change of -68 holders.
  • The largest Ambrx Biopharma Inc seller in Q1 2024 was Darwin Global Management, an estimated $238M sold.

Based on aggregated 13F filings for Q1 2024.